HOME > INVESTOR > ARCHIVES > PRESS RELEASE
November 2007
Lupin gets new Pharmaceutical Research Head


October 2007
Lupin FY 2007-08 Q2 Consolidated Net Profit up 46% to Rs. 756 mn
Lupin acquires in Japan


September 2007
Lupin acquires pharmaceutical business of Rubamin
Lupin wins Ramipril product patent challenge at Federal Circuit


August 2007
Lupin appoints Ramesh Swaminathan as President Finance & Planning


July 2007
Lupin Receives "Best New Manufacturer of the Year" Award fromAmerisourceBergen
Lupin FY 2007-08 Q1 Net Profit up 55% to Rs. 784 mn
Lupin receives DCGI Approval to conduct Combined Phase IIb/III Clinical Trials for it's herbal Psoriasis NCE
Lupin Receives US FDA Approval for Amlodipine
Lupin gets MHRA Approval for Lisinopril in UK


June 2007
Lupin receives Final FDA Approval for Trandolapril


May 2007
Lupin Receives US FDA Approval for Cefadroxil Capsules
Lupin and Symbiotec decide not to pursue their MoU
Lupin receives tentative US FDA Approval for Ziprasidone
Lupin Receives US FDA Approval for Simvastatin Tablets


April 2007
DST and Lupin join hands over Migraine and Psoriasis
Lupin receives US FDA Approval for Novel Formulation of Suprax® Suspension


March 2007
Lupin gets Marketing Approval for Cefpodoxime Proxetil in France


February 2007
Lupin sells Intellectual Property on Perindopril to Servier
Lupin receives US FDA approval for Sertraline


January 2007
Lupin and Aspen decide not to pursue their MOU
Lupin FY 2006-07 Q3 Net Profit up by 27% at Rs.560 mn
Lupin gets tentative US FDA approval for Sertraline